Abstract
Hemophilia B is a hereditary X-linked coagulation disorder. This pathology is caused by various defects in the factor IX gene, which is, being about 34 kb long and consisting of eight exons, localized in the Xq27 locus of the X-chromosome long arm. Mutations were revealed in 56 unrelated patients with hemophilia B in this study by using direct sequencing of factor IX gene functionally important fragments. Forty-six mutations were found with prevailing missense mutations (n = 30). The rest of the mutations were nonsense (n = 4) and splicing (n = 4) mutations, large deletions (n = 3), microdeletions (n = 2), microinsertions (n = 2), and promoter mutations (n = 1). Eleven of 46 mutations were previously unknown for human populations.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yoshitake, S., Schach, B.G., Foster, D.C., et al., Nucleotide sequence of the gene for human factor IX (antihemophilic factor B), Biochemistry, 1985, vol. 24, no. 14, pp. 3736–3750.
Ghosh, K., Quadros, L., and Shetty, S., Spectrum of factor IX gene mutations causing haemophilia B from India, Blood Coagulation Fibrinolysis, 2009, vol. 20, no. 5, pp. 333–336. doi 10.1097/MBC.0b013e32832b27d1
Elmahmoudi, H., Khodjet-El-Khil, H., Ben-Amor, M., et al., Identification of novel and recurrent mutations in Tunisian haemophilia B patients, Haemophilia, 2011, vol. 17, no. 3, pp. 544–545. doi 10.1111/j.13652516.2010.02442x
Awidi, A., Alhattab, D., Bsoul, N., et al., FIX mutation spectrum in haemophilia B patients from Jordan: identification of three novel mutations, Haemophilia, 2011, vol. 17, no. 1, pp. 162–163. doi 10.1111/j.13652516.2010.02365x
Halldén, C., Mårtensson, A., Nilsson, D., et al., Origin of Swedish hemophilia B mutations, J. Thromb. Haemostasis, 2013, vol. 11, no. 11, pp. 2001–2008. doi 10.1111/jth.12410
Li, T., Miller, C.H., Driggers, J., et al., Mutation analysis of a cohort of US patients with hemophilia B, Am. J. Hematol., 2014, vol. 89, no. 4, pp. 375–379. doi 10.1002/ajh.23645
Guo, Z.P., Yang, L.H., Qin, X.Y., et al., Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations, Haemophilia, 2014, vol. 20, no. 6, pp. 859–865. doi 10.1111/hae.12534
Sommer, S.S., Scaringe, W.A., and Hill, K.A., Human germline mutation in the factor IX gene, Mutat. Res., 2001, vol. 487, nos. 1–2, pp. 1–17.
Ketterling, R.P., Vielhaber, E., Bottema, C.D., et al., Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation, Am. J. Human Genet., 1993, vol. 52, no. 1, pp. 152–166.
Karimipoor, M., Kokabee, L., Kamali, E., et al., Molecular analysis of factor IX gene in an Iranian female with severe hemophilia B, Acta Haematol., 2008, vol. 119, no. 3, pp. 151–153. doi 10.1159/ 000128043
Okumura, K., Fujimori, Y., Takagi, A., et al., Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B, Haemophilia, 2008, vol. 14, no. 5, pp. 1088–1093. doi 10.1111/j.1365-2516.2008.01786x
Di Michele, D.M., Immune tolerance induction in haemophilia: evidence and the way forward, J. Thrombosis Haemostasis, 2011, vol. 9, pp. 216–225. doi 10.1111/j.1538-7836.2011.04349x
Shirahata, A., Fukutake, K., Higasa, S., et al., An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan, Haemophilia, 2011, vol. 17, no. 5, pp. 771–776. doi 10.1111/j.1365-2516.2011.02599x
Miller, C.H., Benson, J., Ellingsen, D., et al., F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity, Haemophilia, 2012, vol. 18, no. 3, pp. 375–382. doi 10.1111/j.1365-2516.2011.02700x
Rallapalli, P.M., Kemball-Cook, G., Tuddenham, E.G., et al., An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B, J. Thrombosis Haemostasis, 2013, vol. 11, pp. 1329–1340. doi 10.1111/jth.12276
Reijnen, M.J., Peerlinck, K., Maasdam, D., et al., Hemophilia B Leyden: substitution of thymine for guanine at position–21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter, Blood, 1993, vol. 82, no. 1, pp. 151–158.
Kolkman, J.A. and Mertens, K., Insertion loop 256–268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII, Biochemistry, 2000, vol. 39, pp. 7398–7405.
Di Scipio, R.G., Kurachi, K., and Davie, E.W., Activation of human factor IX (Christmas factor), J. Clin. Invest., 1978, vol. 61, pp. 1528–1538.
Koeberl, D.D., Bottema, C.D., Ketterling, R.P., et al., Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene, Am. J. Hum. Genet., 1990, vol. 47, pp. 202–217.
Liu, J.Z., Li, X., Drost, J., et al., The human factor IX gene as germline mutagen test: samples from Mainland China have the putatively endogenous pattern of mutation, Hum. Mutat., 2000, vol. 16, no. 1, pp. 31–36.
Saad, S., Rowley, G., Tagliavacca, L., et al., First report on UK database of haemophilia B mutations and pedigrees: UK Haemophilia Centers, J. Thrombosis Haemostasis, 1994, vol. 71, no. 5, pp. 563–570.
Giannelli, F., Green, P.M., High, K.A., et al., Haemophilia B: database of point mutations and short additions and deletions—fourth edition, 1993, Nucleic Acids Res., 1993, vol. 21, no. 13, pp. 3075–3087.
Van de Water, N.S., Williams, R., Berry, E.W., et al., Factor IX gene mutations in haemophilia B: a New Zealand population-based study, Haemophilia, 1996, vol. 2, pp. 24–27.
Thompson, A.R., Schoof, J.M., Weinmann, A.F., and Chen, S.H., Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B, Thrombosis Res., 1992, vol. 65, no. 2, pp. 289–295.
Bajaj, S.P., Spitzer, S.G., Welsh, W.J., et al., Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme, J. Biol. Chem., 1990, vol. 265, pp. 2956–2961.
Lusher, J.M. and McMillan, C.W., Severe factor VIII and factor IX deficiency in females, Am. J. Med., 1978, vol. 65, pp. 637–648.
Di Michele, D.M., Gibb, C., Lefkowitz, J.M., et al., Severe and moderate haemophilia A and B in US females, Haemophilia, 2014, vol. 20, no. 2, pp. 136–143. doi 10.1111/hae.12364
Fraser, B.M., Poon, M.C., and Hoar, D.I., Identification of factor IX mutations in haemophilia B: application of polymerase chain reaction and single strand conformation analysis, Hum. Genet., 1992, vol. 88, no. 4, pp. 426–430.
Belvini, D., Salviato, R., Radossi, P., et al., Molecular genotyping of the Italian cohort of patients with hemophilia B, Haematologica, 2005, vol. 90, no. 5, pp. 635–642.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.L. Surin, E.Yu. Demidova, D.S. Selivanova, Yu.A. Luchinina, V.V. Salomashkina, O.S. Pshenichnikova, E.A. Likhacheva, 2016, published in Genetika, 2016, Vol. 52, No. 4, pp. 466–473.
Rights and permissions
About this article
Cite this article
Surin, V.L., Demidova, E.Y., Selivanova, D.S. et al. Mutational analysis of hemophilia B in Russia: Molecular-genetic study. Russ J Genet 52, 409–415 (2016). https://doi.org/10.1134/S1022795416040116
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795416040116